During the past decade, Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o. conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 5 clinical trials were completed. i.e. 83.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." #1 sponsor was "Galapagos NV" with 3 trials, followed by "Camurus AB" with 2 trials sponsored, "Crinetics Pharmaceuticals Inc." with 2 trials sponsored, "Ionis Pharmaceuticals, Inc." with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." #1 collaborator was "Gilead Sciences" with 1 trials as a collaborator and "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are "Acromegaly" (6 trials), "Rheumatoid Arthritis" (4 trials), "Dermatitis, Atopic" (2 trials), "Systemic Lupus Erythematosus" (2 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." in a lesser frequency.

Most popular intervention types in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are "Drug" (14 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "CAM2029 (octreotide subcutaneous depot)" (2 trials), "GLPG0634" (2 trials), "Paltusotine" (2 trials) and "ABP 501" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o." are 15 trials for "All" genders.

Currently, there are NaN active trials in "Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o.". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centrum Nowoczesnych Terapii "Dobry Lekarz" Sp. z o.o., 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".